Guanghua Luo
- Cancer Research top 5%
- Cancer, Lipids, and Metabolism 10
- Cancer-related molecular mechanisms research 8
- Molecular Biology top 10%
- Sphingolipid Metabolism and Signaling 19
- RNA modifications and cancer 9
- Immunology top 10%
- Phagocytosis and Immune Regulation 11
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 9
- Oncology top 10%
-
- Cholesterol and Lipid Metabolism 10
- Lipoproteins and Cardiovascular Health 9
- Co-authors
- Xiaoying ZhangNing XuPeter Nilsson‐EhleLu ZhengJun ZhangMiaomei YuShuang YaoYuehua Feng
- Journals
- SHILAP Revista de lepidopterología (2 papers)PLoS ONE (1 paper)Analytical Chemistry (1 paper)
- Partner nations
- ChinaSwedenUnited States
In The Last Decade
Guanghua Luo
122 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 112
- Cancer Research 386
- Molecular Biology 916
- Immunology 252
- Endocrinology, Diabetes and Metabolism 173
- Oncology 259
Countries citing papers authored by Guanghua Luo
This map shows the geographic impact of Guanghua Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guanghua Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guanghua Luo more than expected).
Fields of papers citing papers by Guanghua Luo
This network shows the impact of papers produced by Guanghua Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guanghua Luo. The network helps show where Guanghua Luo may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Guanghua Luo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 2 | |
| 3 | 2024 | 2 | |
| 4 | 2022 | 8 | |
| 5 | 2022 | 7 | |
| 6 | Paeoniflorin Sensitizes Breast Cancer Cells to Tamoxifen by Downregulating microRNA-15b via the FOXO1/CCND1/β-Catenin Axis | 2021 | 0 |
| 7 | 2020 | 10 | |
| 8 | 2020 | 8 | |
| 9 | Apolipoprotein M could inhibit growth and metastasis of SMMC7721 cells via vitamin D receptor signaling | 2019 | 1 |
| 10 | 2019 | 5 | |
| 11 | 2018 | 37 | |
| 12 | 2018 | 27 | |
| 13 | 2018 | 1 | |
| 14 | 2018 | 10 | |
| 15 | 2018 | 7 | |
| 16 | 2017 | 5 | |
| 17 | Metallothionein 2A genetic polymorphism and its correlation to coronary heart disease. | 2014 | 14 |
| 18 | 2014 | 14 | |
| 19 | [Alterations of CD4+ CD25+ regulatory T cells in patients with idiopathic thrombocytopenic purpura]. | 2007 | 10 |
| 20 | 1994 | 21 |
About Guanghua Luo
Guanghua Luo is a scholar working on Cancer Research, Transplantation and Immunology and Allergy, having authored 132 papers that have together received 1.8k indexed citations. Recurring topics across this work include Sphingolipid Metabolism and Signaling (19 papers), Phagocytosis and Immune Regulation (11 papers), Cholesterol and Lipid Metabolism (10 papers), Cancer, Lipids, and Metabolism (10 papers), Lipoproteins and Cardiovascular Health (9 papers), RNA modifications and cancer (9 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (9 papers) and Cancer-related molecular mechanisms research (8 papers). The work is most often cited by research in Cancer Research (386 citations), Molecular Biology (916 citations) and Immunology (252 citations). Guanghua Luo has collaborated with scholars based in China, Sweden and United States. Frequent co-authors include Xiaoying Zhang, Ning Xu, Peter Nilsson‐Ehle, Lu Zheng, Jun Zhang, Miaomei Yu, Shuang Yao, Yuehua Feng, Yuxia Zhan and Wei Jiang. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and Analytical Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.